PL2702983T3 - Sposób wytwarzania półstałego preparatu zawierającego bispirydynioalkan - Google Patents

Sposób wytwarzania półstałego preparatu zawierającego bispirydynioalkan

Info

Publication number
PL2702983T3
PL2702983T3 PL13179624T PL13179624T PL2702983T3 PL 2702983 T3 PL2702983 T3 PL 2702983T3 PL 13179624 T PL13179624 T PL 13179624T PL 13179624 T PL13179624 T PL 13179624T PL 2702983 T3 PL2702983 T3 PL 2702983T3
Authority
PL
Poland
Prior art keywords
preparation
bispyridiniumalkane
containing semisolid
semisolid
semisolid preparation
Prior art date
Application number
PL13179624T
Other languages
English (en)
Inventor
Sabine Behrends
Andreas Dettmann
Nadine Radischat
Mona Hahn
Original Assignee
Air Liquide
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Air Liquide filed Critical Air Liquide
Publication of PL2702983T3 publication Critical patent/PL2702983T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL13179624T 2012-08-31 2013-08-07 Sposób wytwarzania półstałego preparatu zawierającego bispirydynioalkan PL2702983T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102012215511.2A DE102012215511A1 (de) 2012-08-31 2012-08-31 Verfahren zur Herstellung einer Bispyridiniumalkan enthaltenden halbfesten Zubereitung
EP13179624.5A EP2702983B1 (en) 2012-08-31 2013-08-07 Process for the preparation of a bispyridiniumalkane-containing semisolid preparation

Publications (1)

Publication Number Publication Date
PL2702983T3 true PL2702983T3 (pl) 2019-05-31

Family

ID=48948295

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13179624T PL2702983T3 (pl) 2012-08-31 2013-08-07 Sposób wytwarzania półstałego preparatu zawierającego bispirydynioalkan

Country Status (4)

Country Link
EP (1) EP2702983B1 (pl)
DE (1) DE102012215511A1 (pl)
ES (1) ES2702292T3 (pl)
PL (1) PL2702983T3 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102014107412A1 (de) 2014-05-26 2015-12-17 Schülke & Mayr GmbH Gefärbte desinfizierende Zubereitung auf Basis von Bispyridiniumalkan
EP3106172B1 (de) 2015-06-15 2020-08-05 B. Braun Melsungen AG Antimikrobiell aktive mittel und deren verwendung
DE102017119261A1 (de) * 2017-08-23 2019-02-28 Schülke & Mayr GmbH Octenidindihydrochlorid enthaltendes Mundwasser
CN114901069B (zh) * 2019-12-31 2023-10-20 3M创新有限公司 奥替尼啶盐抗微生物医疗制品

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1533952A (en) 1976-02-25 1978-11-29 Sterling Drug Inc Anti-microbial bis-pyridinium compounds
GB8530796D0 (en) 1985-12-13 1986-01-22 Beecham Group Plc Pharmaceutical composition
EP0727979B1 (en) 1993-10-22 2001-06-27 Smithkline Beecham Corporation Novel composition
GB9616208D0 (en) 1996-08-01 1996-09-11 Smithkline Beecham Plc Novel Compounds
DE19647692C2 (de) 1996-11-05 2002-06-20 Schuelke & Mayr Gmbh Waschendes Desinfektionsmittel zur hygienischen und chirurgischen Händedesinfektion
GB9808470D0 (en) 1998-04-22 1998-06-17 Smithkline Beecham Plc Novel process and apparatus
US9028852B2 (en) 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
DE102005045145A1 (de) * 2005-09-15 2007-03-29 Schülke & Mayr GmbH Verwendung von Octenidindihydrochlorid in halbfesten Zubereitungen
DE102006051891A1 (de) 2006-10-31 2008-05-08 Schülke & Mayr GmbH Antimikrobiell wirksame Zusammensetzung mit einem Gehalt an Bispyridiniumalkan
DE102008011691A1 (de) 2008-02-28 2009-09-10 Schülke & Mayr GmbH Stabilisierte, antimikrobiell wirksame Zusammensetzung mit einem Gehalt an Bispyridiniumalkan
DE102009049506A1 (de) * 2009-10-15 2011-04-21 Schülke & Mayr GmbH Octenidindihydrochlorid enthaltende Wundauflage zur Anwendung bei der Antiseptik von Kathetereintrittsstellen
DE102010044785A1 (de) 2010-09-09 2012-03-15 Beiersdorf Ag Octenidindihydrochlorid als Co-Emulgator in Mikroemulsionen
DE102010044787A1 (de) 2010-09-09 2012-03-15 Beiersdorf Ag Makroemulsionen mit verbesserter Deodorantwirksamkeit

Also Published As

Publication number Publication date
EP2702983B1 (en) 2018-10-10
ES2702292T3 (es) 2019-02-28
EP2702983A1 (en) 2014-03-05
DE102012215511A1 (de) 2014-06-12

Similar Documents

Publication Publication Date Title
ZA201500664B (en) Process for making isoquinoline compounds
IL235826A (en) Diazaspirocycloalkanes and thenaspirocycloalkanes and their preparation
ZA201500603B (en) Process
ZA201502937B (en) Process for the preparation of hydrocarbons
SG11201405870SA (en) Process for the preparation of methionine
EP2916832A4 (en) PROCESS FOR PREPARING PREGABALIN
GB201214326D0 (en) Process
SG11201400939YA (en) Process for the preparation of methoxymelonal
GB201213360D0 (en) Process
PL399419A1 (pl) Sposób wytwarzania 4-metoksydihydrochalkonu
PL399418A1 (pl) Sposób wytwarzania 4-metoksydihydrochalkonu
IL236450A0 (en) Process for the preparation of 5-fluoro-h1-pyrazoles
PT2914574T (pt) Processo novo
EP2852660A4 (en) PROCESS
IL235805A (en) Pyrimidinyl-Diazaspiro compound and process for preparation
PL2702983T3 (pl) Sposób wytwarzania półstałego preparatu zawierającego bispirydynioalkan
ZA201405824B (en) Process for the preparation of substituted phenylpropanones
PL2681199T3 (pl) Sposób wytwarzania (-)-hupercyny A
ZA201502216B (en) Process for the preparation of structured oil phase
IL234440A0 (en) Process for the production of nitroalcohols
HUP1500023A2 (en) A method for the preparation of fingolimod
IL229669A0 (en) Process for the preparation of 1,2,3 triazole 4 carboxamide
HU229987B1 (en) Process for the preparation of pyrimidinyl-piperazines
PL394420A1 (pl) Sposób wytwarzania dilauroilofluoresceiny
PL394378A1 (pl) Sposób otrzymywania E-2-amino-4-nitrostilbenów